Good morning, everyone, and welcome to another working week. We hope the weekend respite, which was extended on this side of the pond due to a holiday, was somehow relaxing and refreshing. Well, regardless, the usual routine of Zoom meetings, Skype calls and deadlines has predictably returned. What can you do? The world keeps spinning, no matter what. So hold on tight, grab a cup of stimulation, and feel free to peruse the tidbits we have assembled for you. Hope your day goes well, and do keep in touch. One more thing, stay safe and wear a mask. …
Researchers have designed a staggering 1,200 clinical trials aimed at testing treatment and prevention strategies against Covid-19 since the start of January, but a new STAT analysis shows the effort has been marked by disorder and disorganization, with huge financial resources wasted. For instance, one in every six trials was designed to study the decades-old malaria drugs hydroxychloroquine or chloroquine, which have been shown to have no benefit in hospitalized patients.
About the Author Reprints
